1. Home
  2. ADTX vs NAOV Comparison

ADTX vs NAOV Comparison

Compare ADTX & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • NAOV
  • Stock Information
  • Founded
  • ADTX 2017
  • NAOV 2003
  • Country
  • ADTX United States
  • NAOV United States
  • Employees
  • ADTX N/A
  • NAOV N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • NAOV Industrial Specialties
  • Sector
  • ADTX Health Care
  • NAOV Health Care
  • Exchange
  • ADTX Nasdaq
  • NAOV Nasdaq
  • Market Cap
  • ADTX 5.3M
  • NAOV 5.4M
  • IPO Year
  • ADTX 2020
  • NAOV N/A
  • Fundamental
  • Price
  • ADTX $2.30
  • NAOV $5.15
  • Analyst Decision
  • ADTX
  • NAOV
  • Analyst Count
  • ADTX 0
  • NAOV 0
  • Target Price
  • ADTX N/A
  • NAOV N/A
  • AVG Volume (30 Days)
  • ADTX 589.6K
  • NAOV 4.9M
  • Earning Date
  • ADTX 05-19-2025
  • NAOV 05-14-2025
  • Dividend Yield
  • ADTX N/A
  • NAOV N/A
  • EPS Growth
  • ADTX N/A
  • NAOV N/A
  • EPS
  • ADTX N/A
  • NAOV N/A
  • Revenue
  • ADTX $133,985.00
  • NAOV $2,558,000.00
  • Revenue This Year
  • ADTX $15,768.94
  • NAOV N/A
  • Revenue Next Year
  • ADTX N/A
  • NAOV N/A
  • P/E Ratio
  • ADTX N/A
  • NAOV N/A
  • Revenue Growth
  • ADTX N/A
  • NAOV 12.05
  • 52 Week Low
  • ADTX $2.04
  • NAOV $1.92
  • 52 Week High
  • ADTX $27,200.00
  • NAOV $16.25
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 30.46
  • NAOV 48.45
  • Support Level
  • ADTX $2.21
  • NAOV $5.86
  • Resistance Level
  • ADTX $2.39
  • NAOV $6.24
  • Average True Range (ATR)
  • ADTX 0.39
  • NAOV 1.58
  • MACD
  • ADTX 0.49
  • NAOV -0.10
  • Stochastic Oscillator
  • ADTX 11.11
  • NAOV 20.77

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Share on Social Networks: